Gestonorone Capronate
CAS No. 1253-28-7
Gestonorone Capronate( —— )
Catalog No. M26565 CAS No. 1253-28-7
Gestonorone Capronate is a progesterone used in benign prostatic hyperplasia and endometrial cancer studies.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 362 | In Stock |
|
| 5MG | 319 | In Stock |
|
| 10MG | 472 | In Stock |
|
| 25MG | 753 | In Stock |
|
| 50MG | 1051 | In Stock |
|
| 100MG | 1414 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGestonorone Capronate
-
NoteResearch use only, not for human use.
-
Brief DescriptionGestonorone Capronate is a progesterone used in benign prostatic hyperplasia and endometrial cancer studies.
-
DescriptionGestonorone Capronate is a progesterone used in benign prostatic hyperplasia and endometrial cancer studies.(In Vitro):After administration of progesterone caproate hindered testosterone reduction, the oxidative pathway remained unaffected. This inhibition of 5α reduction product formation is present at the lowest doses of progesterone caproate and increases progressively with increasing concentrations of progesterone caproate .
-
In VitroThe administration of gestonorone capronate impedes testosterone reduction. The oxydation pathway remains uninfluenced. This inhibition of the formation of 5α-reduction products is present at the lowest dose of gestonorone capronate and is augmented progressively with increasing gestonorone capronate concentration.
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetProstaglandin Receptor
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1253-28-7
-
Formula Weight414.586
-
Molecular FormulaC26H38O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES[H][C@@]12CC[C@](OC(=O)CCCCC)(C(C)=O)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Tafluprost
Tafluprost, a prostaglandin analog, is the selective agonist of fluoroprostaglandin (FP) receptor PGF2α.Tafluprost showed significant IOP-lowering effects without any safety concerns in patients with various types of glaucoma and OH in daily clinical practice and tafluprost is highly effective in any therapeutic pattern.
-
ONO-1301
A stable, orally active, non-prostanoid prostacyclin I2 (PGI2) mimetic and prostacyclin agonist with inhibitory activity against thromboxane A2 synthase.
-
Aligeron
Aligeron, a non-selective prostaglandin (PG) antagonist, inhibits PGF2α- and PGE2-induced blood pressure decreases in cats and can prevent PGF2α-induced diarrhea in mice and PGE2-induced paw edema in rats.
Cart
sales@molnova.com